RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clal Biotechnology Industries Stock

Clal Biotechnology Industries P/S 2024

Clal Biotechnology Industries P/S

238.43

Ticker

CBI.TA

ISIN

IL0011042806

As of Dec 4, 2024, Clal Biotechnology Industries's P/S ratio stood at 238.43, a 15,183.97% change from the 1.56 P/S ratio recorded in the previous year.

The Clal Biotechnology Industries P/S history

Clal Biotechnology Industries Aktienanalyse

What does Clal Biotechnology Industries do?

Clal Biotechnology Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Clal Biotechnology Industries's P/S Ratio

Clal Biotechnology Industries's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Clal Biotechnology Industries's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Clal Biotechnology Industries's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Clal Biotechnology Industries’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Clal Biotechnology Industries stock

What is the price-to-earnings ratio of Clal Biotechnology Industries?

The price-earnings ratio of Clal Biotechnology Industries is currently 238.43.

How has the price-earnings ratio of Clal Biotechnology Industries changed compared to last year?

The price-to-earnings ratio of Clal Biotechnology Industries has increased by 15,183.97% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Clal Biotechnology Industries high compared to other companies?

Yes, the price-to-earnings ratio of Clal Biotechnology Industries is high compared to other companies.

How does an increase in the price-earnings ratio of Clal Biotechnology Industries affect the company?

An increase in the price-earnings ratio of Clal Biotechnology Industries would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Clal Biotechnology Industries affect the company?

A decrease in the price-earnings ratio of Clal Biotechnology Industries would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Clal Biotechnology Industries?

Some factors that influence the price-earnings ratio of Clal Biotechnology Industries are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Clal Biotechnology Industries pay?

Over the past 12 months, Clal Biotechnology Industries paid a dividend of 0.22 ILS . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, Clal Biotechnology Industries is expected to pay a dividend of 0 ILS.

What is the dividend yield of Clal Biotechnology Industries?

The current dividend yield of Clal Biotechnology Industries is 0.63 %.

When does Clal Biotechnology Industries pay dividends?

Clal Biotechnology Industries pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clal Biotechnology Industries?

Clal Biotechnology Industries paid dividends every year for the past 0 years.

What is the dividend of Clal Biotechnology Industries?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clal Biotechnology Industries located?

Clal Biotechnology Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clal Biotechnology Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clal Biotechnology Industries from 4/6/2021 amounting to 0.224 ILS, you needed to have the stock in your portfolio before the ex-date on 3/29/2021.

When did Clal Biotechnology Industries pay the last dividend?

The last dividend was paid out on 4/6/2021.

What was the dividend of Clal Biotechnology Industries in the year 2023?

In the year 2023, Clal Biotechnology Industries distributed 0.224 ILS as dividends.

In which currency does Clal Biotechnology Industries pay out the dividend?

The dividends of Clal Biotechnology Industries are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Clal Biotechnology Industries

Our stock analysis for Clal Biotechnology Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clal Biotechnology Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.